Page last updated: 2024-09-02

landiolol and Adenocarcinoma

landiolol has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayata, K; Kato, T; Katsuda, M; Kitadani, J; Nakamori, M; Nakamura, M; Ojima, T; Tabata, H; Takeuchi, A; Yamaue, H	1

Trials

1 trial(s) available for landiolol and Adenocarcinoma

Article	Year
Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer. The British journal of surgery, 2017, Volume: 104, Issue:8 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Carcinoma, Squamous Cell; Double-Blind Method; Esophageal Neoplasms; Esophagectomy; Female; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Treatment Outcome; Urea	2017

Article

Year

Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer.

The British journal of surgery, 2017, Volume: 104, Issue:8

Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Carcinoma, Squamous Cell; Double-Blind Method; Esophageal Neoplasms; Esophagectomy; Female; Humans; Male; Middle Aged; Morpholines; Postoperative Complications; Treatment Outcome; Urea

2017